Literature DB >> 10076618

A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy.

M Maeta1, H Yamashiro, H Saito, K Katano, A Kondo, S Tsujitani, M Ikeguchi, N Kaibara.   

Abstract

BACKGROUND: Japanese surgeons have been actively performing extended lymphadenectomy (D2, removal of perigastric nodes and nodes along the left gastric, common hepatic, celiac and splenic arteries; or D3, D2 plus removal of nodes in the hepatoduodenal ligament, in the retropancreatic space and along the vessels of the transverse mesocolon). In recent years interest has expanded to superextended lymphadenectomy (D4) of nodes around abdominal aorta (para-aortic lymph nodes from aortic hiatus to aortic bifurcation). Because the therapeutic value of this D4 procedure remains controversial, we initiated a prospective study to compare D3 and D4 lymphadenectomy.
METHODS: Seventy patients with T3 or T4 gastric cancer and without macroscopic metastasis to the para-aortic nodes treated by potentially curative total gastrectomy were randomized to D4 (group A, n = 35) and D3 (group B, n = 35) lymphadenectomies.
RESULTS: Metastases to para-aortic nodes were found in 4 patients. Postoperative survival after D4 resection was not statistically significant between the groups. Postoperative morbidity for group A was greater. In group A 4 patients had postoperative retention of intra-abdominal fluid (lymphorrhea) and 4 others had prolonged diarrhea. One patient in each group died of postoperative complications.
CONCLUSIONS: Surgical treatment of microscopic disease in grossly normal para-aortic lymph nodes may generate occasional long-term survivors. Selecting appropriate candidates who might benefit from D4 resections needs to be refined. On the basis of this study, a nationwide study should be considered.

Entities:  

Mesh:

Year:  1999        PMID: 10076618

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  17 in total

1.  Clinicopathological analysis of patients with gastric cancer in 1200 cases.

Authors:  W X Niu; X Y Qin; H Liu; C P Wang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer.

Authors:  Taisuke Imamura; Shuhei Komatsu; Daisuke Ichikawa; Toshiyuki Kosuga; Kazuma Okamoto; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Advanced gastric cancer with a duplicated hepatic artery: preoperative diagnostic value of multidetector-row computed tomography for surgical resection.

Authors:  Masanori Tokunaga; Shigekazu Ohyama; Souya Nunobe; Naoki Hiki; Tetsu Fukunaga; Yasuyuki Seto; Toshiharu Yamaguchi
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

Review 4.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 5.  Gastric cancer surgery: historical background and perspective in Western countries versus Japan.

Authors:  Chun-Dong Zhang; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Transl Med       Date:  2019-09

Review 6.  On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer.

Authors:  Roman Yarema; Giovanni de Manzoni; Taras Fetsych; Myron Ohorchak; Mykhailo Pliatsko; Maria Bencivenga
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

7.  Postoperative chylous ascites after colorectal cancer surgery.

Authors:  Hideaki Nishigori; Masaaki Ito; Yuji Nishizawa; Atsushi Koyama; Takamaru Koda; Kentaro Nakajima; Nozomi Minagawa; Yusuke Nishizawa; Akihiro Kobayashi; Masanori Sugito; Norio Saito
Journal:  Surg Today       Date:  2012-02-14       Impact factor: 2.549

8.  D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer.

Authors:  Mehmet Mahir Ozmen; Baris Zulfikaroglu; Fusun Ozmen; Munevver Moran; Necdet Ozalp; Selda Seckin
Journal:  Turk J Surg       Date:  2020-12-08

9.  The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer.

Authors:  Giovanni De Manzoni; Gian Luca Baiocchi; Massimo Framarini; Maurizio De Giuli; Domenico D'Ugo; Alberto Marchet; Donato Nitti; Daniele Marrelli; Paolo Morgagni; Andrea Rinnovati; Riccardo Rosati; Franco Roviello; Rosaldo Allieta; Stefano Berti; Umberto Bracale; Patrizio Capelli; Angelo Cavicchi; Natale Di Martino; Annibale Donini; Angelo Filippini; Gianfranco Francioni; Marco Frascio; Alfredo Garofalo; Stefano Maria Giulini; Giovanni Battista Grassi; Paolo Innocenti; Antonio Martino; Gualtiero Mazzocconi; Lorenzo Mazzola; Severino Montemurro; Nicola Palasciano; Gianni Pantuso; Heinrich Pernthaler; Roberto Petri; Diego Piazza; Rosario Sacco; Giovanni Sgroi; Carlo Staudacher; Michele Testa; Carlo Vallicelli; Nereo Vettoretto; Costantino Zingaretti; Lorenzo Capussotti; Mario Morino; Giorgio Maria Verdecchia
Journal:  Updates Surg       Date:  2014-03

Review 10.  Extent of lymph node dissection for adenocarcinoma of the stomach.

Authors:  Simone Mocellin; Peter McCulloch; Hussain Kazi; Joaquin J Gama-Rodrigues; Yuhong Yuan; Donato Nitti
Journal:  Cochrane Database Syst Rev       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.